Concepedia

Author

Fuyou Zhao

First Affiliated Hospital of Bengbu Medical College

Also Known As

FU-YOU ZHAO, Fu-you Zhao, Fuyou Zhao

18

Publications

317

Citations

8

H-Index

25

Concepts

All Affiliations

First Affiliated Hospital of Bengbu Medical CollegeBengbu Medical College81th Hospital of PLAJiangsu Cancer HospitalHarbin Medical University
FZ

About

Fuyou Zhao is an author at First Affiliated Hospital of Bengbu Medical College specializing in cancer research, medicine, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

122

2

Pathology

4

4

122

3

Cell Biology

2

2

80

4

Gastroenterology

1

1

27

5

Immunology

1

1

15

Fuyou Zhao

×

8

Publications

295

Citations

8

H-Index

YearCitations

MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells

Yang Liu, Yumei Li, Rui Wang,

Journal of Experimental & Clinical Cancer Research

2016

89

Impaired gap junctions in human hepatocellular carcinoma limit intrinsic oxaliplatin chemosensitivity: A key role of connexin 26

Yan Yang, Jian Zhu, Na Zhang,

International Journal of Oncology

2015

49

Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma

Fang Su, Jun Zhao, Shukui Qin,

Oncotarget

2017

47

MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9.

Fuyou Zhao, Jie Lv, Huaiyong Gan,

PubMed

2015

33

Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial

Feng Wang, Lin Shen, Weijian Guo,

Nature Medicine

2024

27

Prognostic value of CD117 in cancer: a meta-analysis.

Fuyou Zhao, Yuqing Chen, Qiong Wu,

PubMed

2014

19

High STRN Expression Promotes HCC Invasion and Migration but Not Cell Proliferation or Apoptosis through Facilitating Epithelial‐Mesenchymal Transition

Qianyu Du, Jinghao Yao, Yongchun Zhou,

BioMed Research International

2020

16

Osemitamab in combination with capecitabine and oxaliplatin (CAPOX) as a first line treatment of advanced G/GEJ cancer: Updated data of cohort C from a phase I/IIa, multi-center study (TranStar102/TST001-1002).

Lin Shen, Dan Liu, Ning Li,

Journal of Clinical Oncology

2023

15

Page 1